Ketamine nasal spray ‘improved severe depression within hours’ in US study
Nasal spray containing component of the party drug reduced suicidal urges in study

A nasal spray containing mind-altering “party drug” ketamine had a fast-acting effect on reducing the symptoms of severe depression, including suicidal thoughts, in a study carried out in the US.
All 68 participants were hospitalised and given antidepressants in the study, carried out by Johnson and Johnson-owned research group Janssen in conjunction with the Yale School of Medicine.
Half the patients also received a nasal spray of esketamine, one of the two molecule components in ketamine, while the others received a placebo.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“In just a matter of hours” participants in the ketamine test group and their doctors “measured a significant improvement in symptoms of patients classed as being at high risk of suicide,” says The Independent.
Although the boost wore off over time - after 25 days, both groups were in a similar condition - the rapid effects of the ketamine spray indicate that it could be particularly beneficial for patients at risk of suicide, especially as most conventional antidepressants take four to six weeks to reach their full effect. Further research is needed before the drug can be approved for use in the US.
Ketamine, a class B drug, is licensed for medical use as an anaesthetic, but in recent years scientists have become increasingly interested in its use in mental health treatment.
Because the drug is already licensed as a medicine for its anaesthetic effects, it is already being prescribed for depression “off label” in private clinics, the BBC reports.
Dr James Stone, from the Royal College of Psychiatrists, told the BBC that the results were "interesting", not least because of the involvement of pharmaceutical giant Johnson and Johnson.
“The main reason for its significance is because this is being developed by a drug company and it's potentially quite likely that this medication might become available as a treatment available on the NHS for depression,” he said.
If approved for use on the NHS, Stone said, the spray “would be aimed at people with severe depression as a second or third line of treatment if other drugs haven't worked”, including as a potential alternative to electroconvulsive therapy.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US Published
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US Published
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff Published
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK Published
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK Published
-
Russia's shadow war in Europe
Talking Point Steering clear of open conflict, Moscow is slowly ratcheting up the pressure on Nato rivals to see what it can get away with.
By The Week UK Published
-
Cutting cables: the war being waged under the sea
In the Spotlight Two undersea cables were cut in the Baltic sea, sparking concern for the global network
By The Week UK Published